ACELYRIN

ACELYRIN is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of inflammatory diseases.

Business Model:

Revenue: $3.6M

Employees: 11-50

Detailed ACELYRIN Information

Geographic Data

ACELYRIN headquarters map

Address: 4149 Liberty Canyon Road

City: Agoura Hills

State: CA

Zip: 91301

Country: US

Financial Info

Stage:

series b

Raised Last:

$250M

Raised Total:

$258M

Metrics

5,227,479Website Global Rank

1,751Website Monthly Traffic

Twitter Followers

Description

ACELYRIN is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of inflammatory diseases.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2022 Series C $300M Access Biotechnology
Westlake Village BioPartners
Decheng Capital
Marshall Wace
OrbiMed
Samsara BioCapital
Surveyor Capital
Tybourne Capital Management
venBio Partners
12/2020 Series A -
12/2020 Series A 1 $8M Westlake Village BioPartners
Westlake Village BioPartners
11/2021 Series B $0 Cowen Healthcare Investments
Decheng Capital
Marshall Wace
Matrix Capital Management
OrbiMed
RTW Investments LLC
Samsara BioCapital
Surveyor Capital
Tybourne Capital Management
venBio Partners
Westlake Village BioPartners
Cowen Healthcare Investments
Decheng Capital
Marshall Wace
Matrix Capital Management
OrbiMed
RTW Investments LLC
Samsara BioCapital
Surveyor Capital
Tybourne Capital Management
venBio Partners
Westlake Village BioPartners
9/2022 Series C $0 Access Biotechnology
Cowen Healthcare Investments
Decheng Capital
Marshall Wace
Matrix Capital Management
OrbiMed
Samsara BioCapital
Surveyor Capital
Tybourne Capital Management
venBio Partners
Westlake Village BioPartners
Access Biotechnology
Cowen Healthcare Investments
Decheng Capital
Marshall Wace
Matrix Capital Management
OrbiMed
Samsara BioCapital
Surveyor Capital
Tybourne Capital Management
venBio Partners
Westlake Village BioPartners
Access Biotechnology
Cowen Healthcare Investments
Decheng Capital
Marshall Wace
Matrix Capital Management
OrbiMed
Samsara BioCapital
Surveyor Capital
Tybourne Capital Management
venBio Partners
Westlake Village BioPartners
Access Biotechnology
Cowen Healthcare Investments
Decheng Capital
Marshall Wace
Matrix Capital Management
OrbiMed
Samsara BioCapital
Surveyor Capital
Tybourne Capital Management
venBio Partners
Westlake Village BioPartners
11/2021 Series B 11 $250M AyurMaya
Surveyor Capital
Westlake Village BioPartners
Cowen Healthcare Investments
Decheng Capital
Marshall Wace
OrbiMed
RTW Investments
Samsara BioCapital
Tybourne Capital Management
venBio Partners
Cowen Healthcare Investments
Decheng Capital
Marshall Wace
Matrix Capital Management
OrbiMed
RTW Investments LLC
Samsara BioCapital
Surveyor Capital
Tybourne Capital Management
venBio Partners
Westlake Village BioPartners
12/2020 Series A - Westlake Village BioPartners
Westlake Village BioPartners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research